Omega-3 Breast Cancer Prevention of Recurrence Study for those Stage 0 to III

Official Title: Omega-3 fatty acids and ERPR(-) and Her-2/neu(+) breast cancer prevention


This study is being conducted to find out the effects, of getting a low versus and high dose of omega 3 fatty acid pills as a possible way to lower the risk for ERPR(-) and HER-2/neu (+ or -) breast cancer to come back or recur.

Eligibility criteria:

• Prior diagnosis of Stage 0 to III breast cancer that is ERPR(-) with completion of definitive surgery, radiation therapy for >2 months, chemotherapy or trastuzumab for >6 months.
• 5 years or less from completion of standard therapy.

Contact Information

Shana Straka